ClinVar Genomic variation as it relates to human health
NM_001128126.3(AP4S1):c.289C>T (p.Arg97Ter)
The aggregate germline classification for this variant, typically for a monogenic or Mendelian disorder as in the ACMG/AMP guidelines, or for response to a drug. This value is calculated by NCBI based on data from submitters. Read our rules for calculating the aggregate classification.
Stars represent the aggregate review status, or the level of review supporting the aggregate germline classification for this VCV record. This value is calculated by NCBI based on data from submitters. Read our rules for calculating the review status. The number of submissions which contribute to this review status is shown in parentheses.
No data submitted for somatic clinical impact
No data submitted for oncogenicity
Variant Details
- Identifiers
-
NM_001128126.3(AP4S1):c.289C>T (p.Arg97Ter)
Variation ID: 234924 Accession: VCV000234924.37
- Type and length
-
single nucleotide variant, 1 bp
- Location
-
Cytogenetic: 14q12 14: 31072968 (GRCh38) [ NCBI UCSC ] 14: 31542174 (GRCh37) [ NCBI UCSC ]
- Timeline in ClinVar
-
First in ClinVar Help The date this variant first appeared in ClinVar with each type of classification.
Last submission Help The date of the most recent submission for each type of classification for this variant.
Last evaluated Help The most recent date that a submitter evaluated this variant for each type of classification.
Germline May 29, 2016 Jul 15, 2024 May 22, 2024 - HGVS
-
Nucleotide Protein Molecular
consequenceNM_001128126.3:c.289C>T MANE Select Help Transcripts from the Matched Annotation from the NCBI and EMBL-EBI (MANE) collaboration.
NP_001121598.1:p.Arg97Ter nonsense NM_001254726.2:c.289C>T NP_001241655.1:p.Arg97Ter nonsense NM_001254727.2:c.289C>T NP_001241656.1:p.Arg97Ter nonsense NM_001254728.2:c.289C>T NP_001241657.1:p.Arg97Ter nonsense NM_001254729.2:c.289C>T NP_001241658.1:p.Arg97Ter nonsense NM_007077.5:c.289C>T NP_009008.2:p.Arg97Ter nonsense NC_000014.9:g.31072968C>T NC_000014.8:g.31542174C>T NG_031913.1:g.52863C>T - Protein change
- R97*
- Other names
- -
- Canonical SPDI
- NC_000014.9:31072967:C:T
-
Functional
consequence HelpThe effect of the variant on RNA or protein function, based on experimental evidence from submitters.
- -
-
Global minor allele
frequency (GMAF) HelpThe global minor allele frequency calculated by the 1000 Genomes Project. The minor allele at this location is indicated in parentheses and may be different from the allele represented by this VCV record.
-
0.00020 (T)
-
Allele frequency
Help
The frequency of the allele represented by this VCV record.
-
The Genome Aggregation Database (gnomAD) 0.00009
Trans-Omics for Precision Medicine (TOPMed) 0.00011
Exome Aggregation Consortium (ExAC) 0.00012
NHLBI Exome Sequencing Project (ESP) Exome Variant Server 0.00015
1000 Genomes Project 0.00020
1000 Genomes Project 30x 0.00031
- Links
Genes
Gene | OMIM | ClinGen Gene Dosage Sensitivity Curation |
Variation Viewer
Help
Links to Variation Viewer, a genome browser to view variation data from NCBI databases. |
Related variants | ||
---|---|---|---|---|---|---|
HI score
Help
The haploinsufficiency score for the gene, curated by ClinGen’s Dosage Sensitivity Curation task team. |
TS score
Help
The triplosensitivity score for the gene, curated by ClinGen’s Dosage Sensitivity Curation task team. |
Within gene
Help
The number of variants in ClinVar that are contained within this gene, with a link to view the list of variants. |
All
Help
The number of variants in ClinVar for this gene, including smaller variants within the gene and larger CNVs that overlap or fully contain the gene. |
|||
AP4S1 | - | - |
GRCh38 GRCh37 |
134 | 168 |
Conditions - Germline
Condition
Help
The condition for this variant-condition (RCV) record in ClinVar. |
Classification
Help
The aggregate germline classification for this variant-condition (RCV) record in ClinVar. The number of submissions that contribute to this aggregate classification is shown in parentheses. (# of submissions) |
Review status
Help
The aggregate review status for this variant-condition (RCV) record in ClinVar. This value is calculated by NCBI based on data from submitters. Read our rules for calculating the review status. |
Last evaluated
Help
The most recent date that a submitter evaluated this variant for the condition. |
Variation/condition record
Help
The RCV accession number, with most recent version number, for the variant-condition record, with a link to the RCV web page. |
---|---|---|---|---|
Pathogenic/Likely pathogenic (11) |
criteria provided, multiple submitters, no conflicts
|
May 22, 2024 | RCV000223666.32 | |
Pathogenic (2) |
criteria provided, single submitter
|
Aug 5, 2023 | RCV000525844.14 | |
Pathogenic (4) |
criteria provided, multiple submitters, no conflicts
|
Mar 24, 2023 | RCV000443008.18 | |
Pathogenic (1) |
criteria provided, single submitter
|
Sep 10, 2020 | RCV001260893.9 | |
AP4S1-related disorder
|
not provided (1) |
no classification provided
|
- | RCV001249232.9 |
Submissions - Germline
Classification
Help
The submitted germline classification for each SCV record. (Last evaluated) |
Review status
Help
Stars represent the review status, or the level of review supporting the submitted (SCV) record. This value is calculated by NCBI based on data from the submitter. Read our rules for calculating the review status. This column also includes a link to the submitter’s assertion criteria if provided, and the collection method. (Assertion criteria) |
Condition
Help
The condition for the classification, provided by the submitter for this submitted (SCV) record. This column also includes the affected status and allele origin of individuals observed with this variant. |
Submitter
Help
The submitting organization for this submitted (SCV) record. This column also includes the SCV accession and version number, the date this SCV first appeared in ClinVar, and the date that this SCV was last updated in ClinVar. |
More information
Help
This column includes more information supporting the classification, including citations, the comment on classification, and detailed evidence provided as observations of the variant by the submitter. |
|
---|---|---|---|---|---|
Likely pathogenic
(Jan 06, 2017)
|
criteria provided, single submitter
Method: clinical testing
|
Spastic paraplegia 52, autosomal recessive
Affected status: yes
Allele origin:
inherited
|
Groupe Hospitalier Pitie Salpetriere, UF Genomique du Developpement, Assistance Publique Hopitaux de Paris
Accession: SCV000586778.1
First in ClinVar: May 29, 2016 Last updated: May 29, 2016 |
Comment:
Intellectual disability, moderate; acquired microcephaly (-4SD); hypotonia; epilepsy (starting at 2 months old)
Number of individuals with the variant: 1
Age: 0-9 years
Sex: female
|
|
Pathogenic
(Feb 16, 2018)
|
criteria provided, single submitter
Method: clinical testing
|
not provided
Affected status: unknown
Allele origin:
germline
|
Eurofins Ntd Llc (ga)
Accession: SCV000859814.1
First in ClinVar: Dec 19, 2017 Last updated: Dec 19, 2017 |
Number of individuals with the variant: 3
Sex: mixed
|
|
Pathogenic
(Jan 29, 2021)
|
criteria provided, single submitter
Method: clinical testing
|
not provided
Affected status: yes
Allele origin:
germline
|
Genetic Services Laboratory, University of Chicago
Accession: SCV000593255.2
First in ClinVar: Aug 28, 2017 Last updated: Jan 29, 2022 |
|
|
Pathogenic
(Mar 24, 2023)
|
criteria provided, single submitter
Method: clinical testing
|
Not Provided
Affected status: yes
Allele origin:
germline
|
GeneDx
Accession: SCV000521309.5
First in ClinVar: Mar 08, 2017 Last updated: Apr 15, 2023 |
Comment:
Nonsense variant predicted to result in protein truncation or nonsense mediated decay in a gene for which loss-of-function is a known mechanism of disease; This … (more)
Nonsense variant predicted to result in protein truncation or nonsense mediated decay in a gene for which loss-of-function is a known mechanism of disease; This variant is associated with the following publications: (PMID: 25552650, 29302074, 31130284, 32371413, 33644862, 32895917, 32979048, 31345219, 27535533, 28708303) (less)
|
|
Pathogenic
(Aug 05, 2023)
|
criteria provided, single submitter
Method: clinical testing
|
Spastic paraplegia
Affected status: unknown
Allele origin:
germline
|
Labcorp Genetics (formerly Invitae), Labcorp
Accession: SCV000629434.4
First in ClinVar: Dec 26, 2017 Last updated: Feb 20, 2024 |
Comment:
For these reasons, this variant has been classified as Pathogenic. ClinVar contains an entry for this variant (Variation ID: 234924). This premature translational stop signal … (more)
For these reasons, this variant has been classified as Pathogenic. ClinVar contains an entry for this variant (Variation ID: 234924). This premature translational stop signal has been observed in individual(s) with hereditary spastic paraplegia (PMID: 25552650). It has also been observed to segregate with disease in related individuals. This variant is present in population databases (rs200440467, gnomAD 0.02%). This sequence change creates a premature translational stop signal (p.Arg97*) in the AP4S1 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in AP4S1 are known to be pathogenic (PMID: 21620353, 25552650, 27444738). (less)
|
|
Pathogenic
(Feb 22, 2019)
|
criteria provided, single submitter
Method: clinical testing
|
Spastic paraplegia 52, autosomal recessive
Affected status: yes
Allele origin:
germline
|
Institute for Genomic Medicine (IGM) Clinical Laboratory, Nationwide Children's Hospital
Accession: SCV001423591.1
First in ClinVar: Jul 25, 2020 Last updated: Jul 25, 2020 |
Comment:
[ACMG/AMP: PVS1, PM2, PM3, PP1] This alteration is a null variant in a gene where LOF is a known mechanism of disease [PVS1], is absent … (more)
[ACMG/AMP: PVS1, PM2, PM3, PP1] This alteration is a null variant in a gene where LOF is a known mechanism of disease [PVS1], is absent from or rarely observed in large-scale population databases [PM2], is detected in trans with a known pathogenic variant [PM3], has been shown to cosegregate with disease in multiple affected family members [PP1]. (less)
|
|
Pathogenic
(Sep 10, 2020)
|
criteria provided, single submitter
Method: clinical testing
|
Intellectual disability
Affected status: yes
Allele origin:
unknown
|
Diagnostic Laboratory, Strasbourg University Hospital
Accession: SCV001437993.1
First in ClinVar: Oct 20, 2020 Last updated: Oct 20, 2020 |
|
|
Pathogenic
(Oct 23, 2020)
|
criteria provided, single submitter
Method: clinical testing
|
not provided
(Unknown mechanism)
Affected status: yes
Allele origin:
germline
|
Institute of Medical Genetics and Applied Genomics, University Hospital Tübingen
Accession: SCV001447536.1
First in ClinVar: Nov 28, 2020 Last updated: Nov 28, 2020 |
Clinical Features:
Global developmental delay (present) , Intellectual disability (present) , Hypotonia (present) , Spasticity (present)
Sex: male
|
|
Pathogenic
(Apr 02, 2019)
|
criteria provided, single submitter
Method: clinical testing
|
Spastic paraplegia 52, autosomal recessive
Affected status: yes
Allele origin:
unknown
|
Centre for Mendelian Genomics, University Medical Centre Ljubljana
Accession: SCV001368406.2
First in ClinVar: Jul 06, 2020 Last updated: Dec 12, 2020 |
Comment:
This variant was classified as: Pathogenic. The following ACMG criteria were applied in classifying this variant: PVS1,PS1,PM2.
|
|
Pathogenic
(Dec 19, 2019)
|
criteria provided, single submitter
Method: clinical testing
|
Spastic paraplegia 52, autosomal recessive
(Autosomal recessive inheritance)
Affected status: yes
Allele origin:
inherited
|
Kasturba Medical College, Manipal, Kasturba Medical College, Manipal, Manipal Academy of Higher Education, Manipal, India
Accession: SCV001478364.1
First in ClinVar: Feb 07, 2021 Last updated: Feb 07, 2021 |
Number of individuals with the variant: 3
Family history: yes
Sex: male
|
|
Pathogenic
(Feb 10, 2022)
|
criteria provided, single submitter
Method: clinical testing
|
Spastic paraplegia 52, autosomal recessive
Affected status: unknown
Allele origin:
unknown
|
Fulgent Genetics, Fulgent Genetics
Accession: SCV002792570.1
First in ClinVar: Dec 31, 2022 Last updated: Dec 31, 2022 |
|
|
Pathogenic
(Nov 09, 2023)
|
criteria provided, single submitter
Method: clinical testing
|
Spastic paraplegia 52, autosomal recessive
(Autosomal recessive inheritance)
Affected status: yes
Allele origin:
inherited
|
Institute of Human Genetics, University of Leipzig Medical Center
Accession: SCV004175975.1
First in ClinVar: Dec 17, 2023 Last updated: Dec 17, 2023 |
Comment:
Criteria applied: PVS1,PS4_MOD,PM3,PM2_SUP
Clinical Features:
Focal impaired awareness seizure (present) , Status epilepticus (present) , Cerebral visual impairment (present) , Nystagmus (present) , Microcephaly (present) , Bilateral tonic-clonic seizure with … (more)
Focal impaired awareness seizure (present) , Status epilepticus (present) , Cerebral visual impairment (present) , Nystagmus (present) , Microcephaly (present) , Bilateral tonic-clonic seizure with focal onset (present) , Intellectual disability, severe (present) , Spastic tetraparesis (present) , Dysphagia (present) (less)
Sex: male
|
|
Pathogenic
(Jul 12, 2022)
|
criteria provided, single submitter
Method: clinical testing
|
Spastic paraplegia 52, autosomal recessive
Affected status: unknown
Allele origin:
germline
|
Revvity Omics, Revvity
Accession: SCV002021412.3
First in ClinVar: Nov 29, 2021 Last updated: Feb 04, 2024 |
|
|
Pathogenic
(Mar 26, 2024)
|
criteria provided, single submitter
Method: clinical testing
|
Spastic paraplegia 52, autosomal recessive
Affected status: unknown
Allele origin:
germline
|
Center for Genomic Medicine, King Faisal Specialist Hospital and Research Center
Accession: SCV004806903.1
First in ClinVar: Apr 06, 2024 Last updated: Apr 06, 2024 |
|
|
Pathogenic
(May 22, 2024)
|
criteria provided, single submitter
Method: clinical testing
|
Spastic paraplegia 52, autosomal recessive
Affected status: yes
Allele origin:
biparental
|
Institute of Immunology and Genetics Kaiserslautern
Accession: SCV005077715.1
First in ClinVar: Jul 15, 2024 Last updated: Jul 15, 2024 |
Comment:
ACMG Criteria: PVS1, PS3, PM3, PM2_P, PP5; Variant was found in homozygous state in both the patient and the patient's brother (also affected).
Clinical Features:
Global developmental delay (present) , Absent speech (present) , Motor delay (present) , Seizure (present) , Microcephaly (present) , Failure to thrive (present) , Strabismus … (more)
Global developmental delay (present) , Absent speech (present) , Motor delay (present) , Seizure (present) , Microcephaly (present) , Failure to thrive (present) , Strabismus (present) , Bruxism (present) , Psoriasiform lesion (present) , Tented upper lip vermilion (present) (less)
|
|
Pathogenic
(Jun 21, 2018)
|
no assertion criteria provided
Method: literature only
|
SPASTIC PARAPLEGIA 52, AUTOSOMAL RECESSIVE
Affected status: not provided
Allele origin:
germline
|
OMIM
Accession: SCV000280013.2
First in ClinVar: May 29, 2016 Last updated: Jun 25, 2018 |
Comment on evidence:
For discussion of the c.289C-T transition (c.289C-T, NM_007077.4) in the AP4S1 gene resulting in an arg97-to-ter (R97X) substitution that was found in compound heterozygous state … (more)
For discussion of the c.289C-T transition (c.289C-T, NM_007077.4) in the AP4S1 gene resulting in an arg97-to-ter (R97X) substitution that was found in compound heterozygous state in patients with autosomal recessive spastic paraplegia-52 (SPG52; 614067) by Hardies et al. (2015), see 607243.0002. (less)
|
|
Likely pathogenic
(Oct 01, 2020)
|
no assertion criteria provided
Method: literature only
|
Spastic paraplegia
Affected status: yes
Allele origin:
germline
|
Yale Center for Mendelian Genomics, Yale University
Study: Yale Center for Mendelian Genomics
Accession: SCV002106897.1 First in ClinVar: Mar 28, 2022 Last updated: Mar 28, 2022 |
|
|
Pathogenic
(-)
|
no assertion criteria provided
Method: clinical testing
|
Spastic paraplegia 52, autosomal recessive
Affected status: yes
Allele origin:
germline
|
Dr.Nikuei Genetic Center
Accession: SCV005061407.1
First in ClinVar: Jun 23, 2024 Last updated: Jun 23, 2024 |
|
|
not provided
(-)
|
no classification provided
Method: phenotyping only
|
AP4S1-related disorder
Affected status: yes
Allele origin:
maternal
|
GenomeConnect, ClinGen
Accession: SCV001423167.1
First in ClinVar: Jul 19, 2020 Last updated: Jul 19, 2020 |
Comment:
Variant interpretted as Pathogenic and reported on 04-16-2018 by Lab or GTR ID 26957. GenomeConnect assertions are reported exactly as they appear on the patient-provided … (more)
Variant interpretted as Pathogenic and reported on 04-16-2018 by Lab or GTR ID 26957. GenomeConnect assertions are reported exactly as they appear on the patient-provided report from the testing laboratory. GenomeConnect staff make no attempt to reinterpret the clinical significance of the variant. (less)
Clinical Features:
Abnormal delivery (present) , Short stature (present) , Abnormality of the skull (present) , Abnormality of eye movement (present) , Abnormality of vision (present) , … (more)
Abnormal delivery (present) , Short stature (present) , Abnormality of the skull (present) , Abnormality of eye movement (present) , Abnormality of vision (present) , Abnormality of the nervous system (present) , Cognitive impairment (present) , Abnormality of coordination (present) , Hypertonia (present) , Generalized hypotonia (present) , Memory impairment (present) , Seizures (present) , Abnormality of the curvature of the vertebral column (present) , Joint hypermobility (present) , Hip dysplasia (present) , Abnormality of facial musculature (present) , Abnormality of muscle physiology (present) , Abnormality of esophagus morphology (present) , Gingivitis (present) (less)
Indication for testing: Diagnostic
Age: 0-9 years
Sex: male
Testing laboratory: GeneDx
Date variant was reported to submitter: 2018-04-16
Testing laboratory interpretation: Pathogenic
|
|
click to load more click to collapse |
Germline Functional Evidence
There is no functional evidence in ClinVar for this variation. If you have generated functional data for this variation, please consider submitting that data to ClinVar. |
Citations for germline classification of this variant
HelpTitle | Author | Journal | Year | Link |
---|---|---|---|---|
Defining the clinical, molecular and imaging spectrum of adaptor protein complex 4-associated hereditary spastic paraplegia. | Ebrahimi-Fakhari D | Brain : a journal of neurology | 2020 | PMID: 32979048 |
Identification of mutations in AP4S1/SPG52 through next generation sequencing in three families. | Tessa A | European journal of neurology | 2016 | PMID: 27444738 |
Recessive loss-of-function mutations in AP4S1 cause mild fever-sensitive seizures, developmental delay and spastic paraplegia through loss of AP-4 complex assembly. | Hardies K | Human molecular genetics | 2015 | PMID: 25552650 |
Adaptor protein complex 4 deficiency causes severe autosomal-recessive intellectual disability, progressive spastic paraplegia, shy character, and short stature. | Abou Jamra R | American journal of human genetics | 2011 | PMID: 21620353 |
http://www.egl-eurofins.com/emvclass/emvclass.php?approved_symbol=AP4S1 | - | - | - | - |
Text-mined citations for rs200440467 ...
HelpRecord last updated Nov 03, 2024
This date represents the last time this VCV record was updated. The update may be due to an update to one of the included submitted records (SCVs), or due to an update that ClinVar made to the variant such as adding HGVS expressions or a rs number. So this date may be different from the date of the “most recent submission” reported at the top of this page.